Amneal Pharmaceuticals (STU:2DT) Change In Receivables : €-117 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Amneal Pharmaceuticals Change In Receivables?

Amneal Pharmaceuticals's change in receivables for the quarter that ended in Mar. 2024 was €-51 Mil. It means Amneal Pharmaceuticals's Accounts Receivable increased by €51 Mil from Dec. 2023 to Mar. 2024 .

Amneal Pharmaceuticals's change in receivables for the fiscal year that ended in Dec. 2023 was €115 Mil. It means Amneal Pharmaceuticals's Accounts Receivable declined by €115 Mil from Dec. 2022 to Dec. 2023 .

Amneal Pharmaceuticals's Accounts Receivable for the quarter that ended in Mar. 2024 was €615 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Amneal Pharmaceuticals's Days Sales Outstanding for the three months ended in Mar. 2024 was 92.60.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Amneal Pharmaceuticals's liquidation value for the three months ended in Mar. 2024 was €-2,428 Mil.

Amneal Pharmaceuticals Change In Receivables Historical Data

The historical data trend for Amneal Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amneal Pharmaceuticals Change In Receivables Chart

Amneal Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-120.30

14.14

-14.43

-74.64

115.36

Amneal Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															183.48	-119.17	-18.18	71.41	-51.28

Amneal Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-117 Mil.

Amneal Pharmaceuticals (STU:2DT) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Amneal Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	615.439	/	606.456	*	91
=	92.60

2. In Ben Graham's calculation of liquidation value, Amneal Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Amneal Pharmaceuticals's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	42.798	-	3195.164	+	0.75 * 615.439	+	0.5 * 525.001
=	-2,428

Amneal Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of Amneal Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Amneal Pharmaceuticals (STU:2DT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amneal Pharmaceuticals Inc (STU:2DT) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

AMRX:USA 2DT:Germany

Address

400 Crossing Boulevard, 3rd Floor, Bridgewater, NJ, USA, 08807

Website

https://www.amneal.com

Amneal Pharmaceuticals Inc is a generic pharmaceutical manufacturer. The company's reportable segments are Generic Products, Specialty products, and AvKARE. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals, and the Specialty segment is engaged in the development, promotion, sale and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies.

Amneal Pharmaceuticals (STU:2DT) Headlines

No Headlines